Beijing Cosci-Med Ltd.
CoSci is a National High-Tech Company focusing on development of add-on value oral solid dosage forms with better clinical benefits. The company has been awarded “National Demonstration Institution on Tech-Transfer”, “Beijing Technology RnD Institution”, “G20 Project – High-Value Service Enterprise”.
The company has developed a series of modified-release oral solid formulations, to serve the client and the national healthcare need. CoSci has established 13 technology platforms regarding sophisticated drug formulation, has was granted 83 national and international patents around its formulation and process capabilities. CoSci has served more than 60 partners around the world. The company has developed world class formulations and technologies such as taste masking pediatric granules, precise dosing drugs. CoSci has also built its own Orphan Drug series in order to help such niche population of our citizens suffering from rare diseases.
The company has taken place in National projects such as “11th five-year plan”, “12th five-year plan” and “13th five-year plan”.
CoSci plans to become a world-class innovative organization within the next 2 years, in order to serve the industry and the society with better formulation technologies.